MOXIVIB CV 625 TABLET (DPCO) "AMOXYCILLIN 500mg. IP + CLAVULANIC ACID 125mg. IP

Moxivib CV 625 Tablet is an antibacterial tablet used for respiratory, sinus, ear, skin and urinary tract infections. Main uses: lower respiratory tract infections caused by susceptible beta-lactamase-producing bacteria; acute bacterial otitis media caused by susceptible beta-lactamase-producing bacteria; sinusitis caused by susceptible beta-lactamase-producing bacteria; skin and skin structure infections caused by susceptible beta-lactamase-producing bacteria; urinary tract infections caused by susceptible beta-lactamase-producing bacteria.

Common side effects of Moxivib CV 625 Tablet include diarrhoea or loose stools; nausea; skin rash and urticaria (hives); vomiting; vaginitis; abdominal discomfort and flatulence. Get medical help at once if you notice serious allergic (anaphylactic) reactions; severe cutaneous adverse reactions (severe skin reactions); liver problems including cholestatic jaundice and hepatitis.

Each Moxivib CV 625 tablet contains Amoxycillin 500 mg + Clavulanic Acid 125 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Moxivib CV 625 Tablet only as your doctor advises.

The MRP of Moxivib CV 625 Tablet is ₹118.06 for a pack of 10x6 (Alu Alu). For chemists and distributors, the PTR is ₹89.95 and the PTS is ₹80.96.

Each Moxivib CV 625 tablet contains Amoxycillin 500 mg + Clavulanic Acid 125 mg. It comes in a pack of 10x6 (Alu Alu).

Amoxycillin works by stopping susceptible bacteria from building their cell walls, so they cannot stay alive. Clavulanic acid supports it by blocking the beta-lactamase enzyme that some bacteria produce to defend themselves against penicillins, which allows amoxycillin to carry on acting against those bacteria. The two together help cover infections caused by beta-lactamase-producing organisms.

Must not be used in patients with a history of a serious allergic reaction to amoxycillin, clavulanic acid or other beta-lactam antibiotics such as penicillins and cephalosporins. Must not be used in patients with a previous history of cholestatic jaundice or liver dysfunction caused by this combination. Must not be used in patients with mononucleosis, as a skin rash usually develops. Check with a doctor first if you have liver or kidney problems, are pregnant or are breastfeeding. Check with a doctor first if you develop rash, yellowing of the skin, or severe or persistent diarrhoea during treatment.

Moxivib CV 625 Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.